CRAFITY score is associated with overall survival in patients with hepatocellular carcinoma treated with transarterial chemoembolisation

被引：0

作者：

Veelken, Rhea ^{[1
]}

Olbrich, Anne ^{[1
]}

Schindler, Aaron ^{[1
]}

Lieb, Sabine ^{[1
]}

Fischer, Janett ^{[1
]}

Ebel, Sebastian ^{[2
]}

Denecke, Timm ^{[2
]}

Berg, Thomas ^{[1
]}

van Boemmel, Florian ^{[1
]}

机构：

[1] Univ Hosp Leipzig, Div Hepatol, Dept Med 2, Leipzig, Germany

[2] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-299

引用

页码：S507 / S507

页数：1

共 50 条

[11] Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
Kim, D. Y.
Ryu, H. J.
Choi, J. Y.
Park, J. Y.
Lee, D. Y.
Kim, B. K.
Kim, S. U.
Ahn, S. H.
Chon, C. Y.
Han, K. -H.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (11) : 1343 - 1350
[12] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
Chen, Lufeng
Su, Hongying
Shao, Haibo
Xu, Ke
Liang, Songnian
Liu, Ling
HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
[13] Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study
Mishra, Gauri
Dev, Anouk
Paul, Eldho
Kemp, William
Majeed, Ammar
Lubel, John
Bell, Sally
Gow, Paul
Nicoll, Amanda
Sood, Siddharth
Thompson, Alex
Ryan, Marno
Roberts, Stuart K.
HEPATOMA RESEARCH, 2021, 7
[14] Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
Bao, Dengke
Ba, Yanna
Zhou, Feng
Zhao, Jing
Yang, Qi
Ge, Naijian
Guo, Xu
Wu, Zhenbiao
Zhang, Hongxin
Yang, Hushan
Wan, Shaogui
Xing, Jinliang
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 791 - 799
[15] Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
Dengke Bao
Yanna Ba
Feng Zhou
Jing Zhao
Qi Yang
Naijian Ge
Xu Guo
Zhenbiao Wu
Hongxin Zhang
Hushan Yang
Shaogui Wan
Jinliang Xing
Cancer Chemotherapy and Pharmacology, 2016, 78 : 791 - 799
[16] Prognostic Score predicting overall survival of Patients with Intermediate Stage of Hepatocellular Carcinoma after Transarterial Chemoembolization
Jarupongprapa, Saharat
Nimanong, Supot
Chainuvati, Siwaporn
Charatcharoenwitthaya, Phunchai
Tanwandee, Tawesak
Chotiyaputta, Watcharasak
HEPATOLOGY, 2015, 62 : 444A - 445A
[17] Hepatitis C patients with hepatocellular carcinoma undergoing transarterial chemoembolisation
Pang, J.
Power, M.
Jacques, E.
Lam, P.
Chu, F.
Freiman, J.
Liauw, W.
Paven, G.
Zekry, A.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 64 - 64
[18] Nomograms including the controlling nutritional status score in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation for prediction survival: a retrospective analysis
Chen, Yi
Xu, Wen-ji
Yang, Yi
Xin, Yu-Jing
Zhang, Xin-Yuan
Li, Xiao
Zhou, Xiang
BRITISH JOURNAL OF NUTRITION, 2022, 128 (10) : 1966 - 1974
[19] The CRAFITY score to predict hepatocellular carcinoma disease control rate at month 12 in patients undergoing transarterial chemoembolization
Veelken, Rhea
Olbrich, Anne
Lieb, Sabine
Schindler, Aaron
Herber, Adam
Ebel, Sebastian
Denecke, Timm
Berg, Thomas
van Bommel, Florian
JOURNAL OF HEPATOLOGY, 2024, 80 : S404 - S404
[20] Predictors of survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization
Doan, P. L.
O'Neil, B. H.
Moore, D. T.
Bernard, S. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →